Nancy E. Dempze’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.18M Buy
5,990
+359
+6% +$367K 3.44% 8
2026
Q1
$5.18M Buy
5,631
+140
+3% +$142K 2.84% 11
2025
Q4
$5.9M Buy
5,491
+1,487
+37% +$1.42M 3.07% 9
2025
Q3
$3.06M Buy
4,004
+1,243
+45% +$925K 1.68% 24
2025
Q2
$2.15M Buy
2,761
+387
+16% +$301K 1.24% 30
2025
Q1
$1.96M Buy
2,374
+244
+11% +$203K 1.18% 31
2024
Q4
$1.64M Sell
2,130
-515
-19% -$426K 0.95% 34
2024
Q3
$2.34M Buy
+2,645
New +$2.38M 1.31% 28

Other funds holding LLY

Nancy E. Dempze's LLY Position: Q2 2026 in Review

Nancy E. Dempze increased its Eli Lilly (LLY) stake by 6.4% in Q2 2026, buying an estimated $367K and bringing the position to 5,990 shares worth $7.18M. The position accounts for 3.44% of the portfolio, ranked #8.

Nancy E. Dempze first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Nancy E. Dempze held 5,990 shares of Eli Lilly worth $7.18M as of Q2 2026.
  • Nancy E. Dempze bought 359 Eli Lilly shares in Q2 2026, an estimated $367K.
  • Eli Lilly made up 3.44% of Nancy E. Dempze's portfolio in Q2 2026, its #8 holding.
  • Nancy E. Dempze first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nancy E. Dempze's 13F filing for Q2 2026, filed 13 Aug 2026.